Our Company

Our Company

Corporate Responsibility

Corporate Responsibility

Disclosures

Derived from the expression 'securing health for all of us', CSL Seqirus has public health protection at its core.
Learn more

At CSL Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.
Learn more
Expertise

Expertise

Influenza

Antivenom & Q fever Vaccines

In-licensing

Influenza

Pandemic Response Solutions

CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia.
Learn more

CSL Seqirus is on the front line of battling influenza, working hard to suppress costly and life-threatening epidemics and pandemics. Vaccination is the most effective way to prevent influenza .
Learn more
R&D

R&D

Research Practices

Investigator Initiated Studies

Our CSL Seqirus research and development group provides support to ensure the conditions are optimised for efficient vaccine manufacture. Activities also focus on improving the effectiveness of current influenza vaccines and their manufacturing processes.
Learn more

At CSL Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice.
Learn more
Manufacturing

Manufacturing

Global Manufacturing Network

Technologies

Technical Development

Quality & Safety

One of the largest influenza vaccine companies in the world, CSL Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world.
Learn more

CSL Seqirus utilises both egg and cell-based production technologies and we offer a broadest portfolio of influenza vaccines. We have commercialised the only adjuvanted seasonal influenza vaccine for older adults and paediatrics and offer two different types of quadrivalent influenza vaccines.
Learn more
Products
Careers

Careers

See Yourself at CSL Seqirus

Discover Our People

Diversity and Inclusion

How we care for you at CSL Seqirus

When you join CSL Seqirus, you join a team dedicated to protecting people and communities from influenza. It's a feeling of purpose and possibility that inspires us every day.
Learn more

It doesn't matter whether you are a scientist or an administrator, a marketer or an operator - as long as you are inspired by the chance to create something that will help others, you can find your role at CSL Seqirus.
Learn more

MEDIA

The CSL Seqirus media relations team only responds to calls and emails from professional journalists. If you have a general media enquiry, want to request access to our multimedia library or receive our news releases, please contact the media relations team via the below contact information.

Asia Pacific

Hamish Walsh
Mobile: +61 422 424 338
Email: hamish.walsh@seqirus.com

AP-CRP-23-0001

CSL privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.

Read Policy

Must Confirm

Home